Literature DB >> 25261267

Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation.

Damiano Magrì1, Piergiuseppe Agostoni2, Ugo Corrà3, Claudio Passino4, Domenico Scrutinio5, Pasquale Perrone-Filardi6, Michele Correale7, Gaia Cattadori8, Marco Metra9, Davide Girola10, Massimo F Piepoli11, AnnaMaria Iorio12, Michele Emdin13, Rosa Raimondo14, Federica Re15, Mariantonietta Cicoira16, Romualdo Belardinelli17, Marco Guazzi18, Giuseppe Limongelli19, Francesco Clemenza20, Gianfranco Parati21, Maria Frigerio10, Matteo Casenghi22, Angela B Scardovi23, Alessandro Ferraironi23, Andrea Di Lenarda24, Maurizio Bussotti25, Anna Apostolo8, Stefania Paolillo6, Rocco La Gioia5, Paola Gargiulo26, Pietro Palermo8, Chiara Minà20, Stefania Farina8, Elisa Battaia16, Antonello Maruotti27, Giuseppe Pacileo19, Mauro Contini8, Fabrizio Oliva10, Roberto Ricci23, Gianfranco Sinagra12.   

Abstract

BACKGROUND: Oxygen uptake at the anaerobic threshold (VO2AT), a submaximal exercise-derived variable, independent of patients' motivation, is a marker of outcome in heart failure (HF). However, previous evidence of VO2AT values paradoxically higher in HF patients with permanent atrial fibrillation (AF) than in those with sinus rhythm (SR) raised uncertainties.
DESIGN: We tested the prognostic role of VO2AT in a large cohort of systolic HF patients, focusing on possible differences between SR and AF.
METHODS: Altogether 2976 HF patients (2578 with SR and 398 with AF) were prospectively followed. Besides a clinical examination, each patient underwent a maximal cardiopulmonary exercise test (CPET).
RESULTS: The follow-up was analysed for up to 1500 days. Cardiovascular death or urgent cardiac transplantation occurred in 303 patients (250 (9.6%) patients with SR and 53 (13.3%) patients with AF, p = 0.023). In the entire population, multivariate analysis including peak oxygen uptake (VO2) showed a prognostic capacity (C-index) similar to that obtained including VO2AT (0.76 vs 0.72). Also, left ventricular ejection fraction, ventilation vs carbon dioxide production slope, β-blocker and digoxin therapy proved to be significant prognostic indexes. The receiver-operating characteristic (ROC) curves analysis showed that the best predictive VO2AT cut-off for the SR group was 11.7 ml/kg/min, while it was 12.8 ml/kg/min for the AF group.
CONCLUSIONS: VO2AT, a submaximal CPET-derived parameter, is reliable for long-term cardiovascular mortality prognostication in stable systolic HF. However, different VO2AT cut-off values between SR and AF HF patients should be adopted. © The European Society of Cardiology 2014.

Entities:  

Keywords:  Heart failure; anaerobic threshold; atrial fibrillation; exercise; prognosis

Mesh:

Year:  2014        PMID: 25261267     DOI: 10.1177/2047487314551546

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  8 in total

Review 1.  Heart rate during exercise: mechanisms, behavior, and therapeutic and prognostic implications in heart failure patients with reduced ejection fraction.

Authors:  Stefania Paolillo; Piergiuseppe Agostoni; Fabiana De Martino; Francesca Ferrazzano; Fabio Marsico; Paola Gargiulo; Elisabetta Pirozzi; Caterina Marciano; Santo Dellegrottaglie; Pasquale Perrone Filardi
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 2.  Modulation of angiotensin II signaling following exercise training in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Hanjun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

3.  Impact of BNP level and peak VO2 on future heart failure events: comparison between sinus rhythm and atrial fibrillation.

Authors:  Yuko Kato; Shinya Suzuki; Tokuhisa Uejima; Hiroaki Semba; Hiroto Kano; Shunsuke Matsuno; Hideaki Takai; Takayuki Otsuka; Yuji Oikawa; Kazuyuki Nagashima; Hajime Kirigaya; Koichi Sagara; Takashi Kunihara; Junji Yajima; Hitoshi Sawada; Tadanori Aizawa; Takeshi Yamashita
Journal:  Heart Vessels       Date:  2016-08-22       Impact factor: 2.037

4.  Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.

Authors:  Rachel E Klaren; Brian M Sandroff; Bo Fernhall; Robert W Motl
Journal:  Sports Med       Date:  2016-09       Impact factor: 11.136

Review 5.  Exercise and heart failure: an update.

Authors:  Gaia Cattadori; Chiara Segurini; Anna Picozzi; Luigi Padeletti; Claudio Anzà
Journal:  ESC Heart Fail       Date:  2017-12-13

6.  The MECKI score initiative: Development and state of the art.

Authors:  Elisabetta Salvioni; Alice Bonomi; Federica Re; Massimo Mapelli; Irene Mattavelli; Giuseppe Vitale; Filippo M Sarullo; Pietro Palermo; Fabrizio Veglia; Piergiuseppe Agostoni
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

7.  Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers.

Authors:  Gaia Cattadori; Silvia Di Marco; Stefania Farina; Giuseppe Limongelli; Emanuele Monda; Roberto Badagliacca; Silvia Papa; Lucia Tricarico; Michele Correale
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

Review 8.  Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation.

Authors:  Stefania Paolillo; Angela B Scardovi; Jeness Campodonico
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.